BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

939 related articles for article (PubMed ID: 9680502)

  • 1. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
    Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
    Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations.
    Hirose M; Furukawa Y; Kurogouchi F; Nakajima K; Miyashita Y; Chiba S
    J Pharmacol Exp Ther; 1998 Jul; 286(1):70-6. PubMed ID: 9655843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
    Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
    Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-type natriuretic peptide in chronic renal failure and its action in humans.
    Igaki T; Itoh H; Suga S; Hama N; Ogawa Y; Komatsu Y; Mukoyama M; Sugawara A; Yoshimasa T; Tanaka I; Nakao K
    Kidney Int Suppl; 1996 Jun; 55():S144-7. PubMed ID: 8743538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide infusions in acute myocardial infarction.
    Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
    Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions.
    Imura H; Nakao K; Itoh H
    Front Neuroendocrinol; 1992 Jul; 13(3):217-49. PubMed ID: 1334000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
    Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
    Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.
    Stevens TL; Burnett JC; Kinoshita M; Matsuda Y; Redfield MM
    J Clin Invest; 1995 Mar; 95(3):1101-8. PubMed ID: 7883958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
    Sano T; Morishita Y; Matsuda Y; Yamada K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):825-31. PubMed ID: 1346647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of dendroaspis natriuretic peptide and its binding to NPR-A receptor in rabbit kidney.
    Kim SM; Kim YA; Kim SY; Kim SH; Cho KW; Kim SZ
    Regul Pept; 2011 Feb; 167(1):42-9. PubMed ID: 21130122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptides in relation to the cardiac innervation and conduction system.
    Hansson M
    Microsc Res Tech; 2002 Sep; 58(5):378-86. PubMed ID: 12226807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptides and their therapeutic potential.
    Cho Y; Somer BG; Amatya A
    Heart Dis; 1999; 1(5):305-28. PubMed ID: 11720638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
    Zavala L; Barbella Y; Israel A
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
    Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H
    Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of natriuretic peptides in cGMP production in fetal cardiac bypass.
    Heeb EA; Baker RS; Lam C; Basu M; Lubbers W; Duffy JY; Eghtesady P
    Ann Thorac Surg; 2009 Mar; 87(3):841-7. PubMed ID: 19231402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute cardiac volume load-related changes in plasma atrial natriuretic peptide and N-terminal pro-B-type natriuretic peptide concentrations in healthy dogs.
    Hori Y; Sano N; Kanai K; Hoshi F; Itoh N; Higuchi S
    Vet J; 2010 Sep; 185(3):317-21. PubMed ID: 19709913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
    J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of natriuretic peptides in patients on hemodialysis.
    Takahashi M; Nagake Y; Ichikawa H; Kawabata K; Nakazono H; Hirata K; Ogura T; Makino H
    Res Commun Mol Pathol Pharmacol; 1996 Apr; 92(1):19-30. PubMed ID: 8733825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic peptides in the lung modulated by pneumonectomy.
    Tayama K; Mifune H; Takamori S; Ohtsuka S; Hayashi A; Tamura K; Aoyama Y; Shirouzu K
    Ann Thorac Cardiovasc Surg; 1998 Dec; 4(6):325-31. PubMed ID: 9914460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.